Pinpoint Pupils, an Empty Acetaminophen Bottle, and a Patient Who Wants to Walk Out
A 24-year-old man is found unresponsive in a parked car by a friend who called 911. On arrival he has a respiratory rate of 6 and shallow, pinpoint pupils, cyanosis, and a track mark on the left antecubital fossa. Bystanders say he 'has been using again.' There is an empty 100-count bottle of 500 mg acetaminophen caplets in the car with a receipt dated yesterday; the time of ingestion is unknown and he may have been in the car for many hours. SpO2 82% on room air, HR 54, BP 96/60, T 36.2 C, glucose 110. He moans to painful stimuli but does not open his eyes.
1. State your airway and ventilation plan and how you will titrate naloxone. Define what 'adequate' means here and what you will do if it is not achieved.
Read the worked answer
The lethal problem is ventilation, not consciousness. Start with airway positioning, suction, an oral or nasopharyngeal airway as tolerated, and bag-mask ventilation with high-flow oxygen. Bagging is the intervention that saves him; naloxone only buys the time until he breathes on his own.
Naloxone titration
- 0.04-0.4 mg IV, repeated every 2-3 minutes and titrated upward as needed (intranasal or intramuscular if there is no access).
- The target is an adequate respiratory rate and tidal volume - roughly a respiratory rate above 10-12 with visible chest rise and improving saturation - not full wakefulness.
- Rationale: full reversal in a chronic opioid user precipitates acute withdrawal with agitation, vomiting, and aspiration, and can produce noncardiogenic pulmonary edema and arrhythmia. It makes the airway harder to manage, not easier.
If adequate ventilation is not achieved
- Reassess the diagnosis. Persistent apnea after two or three doses suggests a co-ingestant (alcohol, benzodiazepine, clonidine), a head injury, or another cause; glucose is 110, so hypoglycemia is unlikely.
- Proceed to intubation. Naloxone does not fix an airway that cannot be protected.
- Plan for redosing. Naloxone lasts 30-90 minutes, shorter than most opioids; expect recurrent respiratory depression and consider an infusion with continuous monitoring. Watch for aspiration and for pulmonary edema after reversal.
2. Why does the acetaminophen matter even though he will wake up, and what determines whether he receives N-acetylcysteine?
Read the worked answer
Why it matters
- One hundred 500 mg tablets is up to 50 grams - a massive ingestion with a real risk of fulminant hepatic failure, and it is entirely asymptomatic for the first 24 hours. He will look and feel fine while his liver is being destroyed. Standard urine drug screens do not detect acetaminophen, so nothing on the routine panel will flag it.
- The time of ingestion is unknown, which is the crux: the Rumack-Matthew nomogram requires a known time and a level drawn at least 4 hours after ingestion. With an unknown time, you cannot place him on the nomogram reliably.
What determines treatment
- Draw an acetaminophen level, hepatic transaminases, INR, creatinine, lipase, and a pregnancy test if applicable, and assess for co-ingestants including ethanol.
- Do not wait for the level to start N-acetylcysteine if the history suggests a large ingestion with an unknown time, or if transaminases are already elevated. NAC is most effective within 8 hours but retains benefit well beyond that, and it is a safe drug - the risk asymmetry favors treating.
- Repeat the level and transaminases; a detectable level with rising transaminases or a rising INR means treatment continues and the patient needs a liver-failure-capable center, not a discharge.
The judgment
The opioid is the dramatic problem and the acetaminophen is the quiet one. Treating only what you can see on the monitor is how a patient is discharged from the emergency department and readmitted in hepatic failure.
3. He wakes after naloxone, becomes agitated, and says he is leaving. What is your disposition plan and how do you handle the confrontation?
Read the worked answer
Disposition
- Observation is not optional. Naloxone's effect wears off before the opioid does, so recurrent respiratory depression is expected; continue continuous monitoring for at least 4-6 hours (longer for methadone or long-acting formulations) and longer still until the acetaminophen question is resolved.
- He is not medically cleared while a potentially massive acetaminophen ingestion is unaddressed and while transaminases and levels are pending.
- Consult toxicology or the poison center, plus behavioral health and social work; offer a take-home naloxone kit and treatment linkage, which is a clinical intervention, not a courtesy.
Handling the confrontation
- Lower the temperature: he is in precipitated withdrawal, which is genuinely miserable. Explain that the agitation is from the medication, that it will pass, and what you are actually watching for.
- Assess decision-making capacity regarding this specific decision: can he state what happens if he leaves now and what the alternative is?
- Notify the provider and supervisor, document his stated reasons and his demonstrated understanding of the risks, and follow the against-medical-advice policy consistent with law and hospital policy. You cannot physically detain him without a legal basis, but you can make sure he is not leaving with untreated life-threatening toxicity.
- The trap is letting 'he woke up and he's talking' substitute for a medical clearance. The opioid is treated; the liver is not yet assessed.